Previous close | 26.05 |
Open | 31.40 |
Bid | 30.65 |
Ask | 33.20 |
Strike | 135.00 |
Expiry date | 2024-06-21 |
Day's range | 31.40 - 31.40 |
Contract range | N/A |
Volume | |
Open interest | 2.39k |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.